{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:55:22Z","timestamp":1793746522291,"version":"4.6.1"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Aging"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Estrogen receptor-positive (ER\n                    <jats:sup>+<\/jats:sup>\n                    ) breast cancer is the most common subtype of breast cancer and is an age-related disease. How systemic and tumor microenvironment hormone signaling intersects with chronic inflammation and how this shapes aging-associated tumor biology remain incompletely understood. Here, using an aged rat model of ER\n                    <jats:sup>+<\/jats:sup>\n                    tumors, we identify age-associated differences in tumor development and immune features. In parallel, analysis of samples from patients with ER\n                    <jats:sup>+<\/jats:sup>\n                    \/HER2\n                    <jats:sup>\u2212<\/jats:sup>\n                    breast cancer and age-matched controls demonstrated estrone-predominant systemic estrogen patterns and increased tumor HSD17B7 expression in older patients, consistent with enhanced local estrone-to-estradiol conversion. In patient-derived organoids from older women, pharmacologic inhibition of HSD17B7 reduced estrogen conversion and proliferation-associated transcriptional programs. Tumors from older patients also exhibited chemokine enrichment, including CCL2, associated with immunosuppressive macrophage features. Targeting both estrogen signaling and chemokine pathways attenuated macrophage polarization ex vivo. These findings support a model linking age-associated hormonal and inflammatory changes to features of a tumor-permissive microenvironment in ER\n                    <jats:sup>+<\/jats:sup>\n                    breast cancer.\n                  <\/jats:p>","DOI":"10.1038\/s43587-026-01173-4","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T09:02:23Z","timestamp":1785142943000},"page":"1695-1716","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Systemic and local chronic inflammation and hormone disposition promote a tumor-permissive environment for breast cancer in older women"],"prefix":"10.1038","volume":"6","author":[{"given":"Neil","family":"Carleton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander Chih-Chieh","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8564-2392","authenticated-orcid":false,"given":"Sanghoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruxuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7410-9514","authenticated-orcid":false,"given":"Daniel D.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagmohan","family":"Hooda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda R.","family":"Klei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lora H.","family":"Rigatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Newsome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dixcy Jaba Sheeba","family":"John Mary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"Atkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Raymond E.","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4339-1382","authenticated-orcid":false,"given":"Thomas D.","family":"Nolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick J.","family":"Oberly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Poirier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia J.","family":"Diego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4880-7172","authenticated-orcid":false,"given":"Peter C.","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5447-1014","authenticated-orcid":false,"given":"George C.","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3988-5419","authenticated-orcid":false,"given":"Michael T.","family":"Lotze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla F.","family":"McAuliffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2386-9553","authenticated-orcid":false,"given":"Ioannis K.","family":"Zervantonakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2537-6923","authenticated-orcid":false,"given":"Steffi","family":"Oesterreich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9917-514X","authenticated-orcid":false,"given":"Adrian V.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"key":"1173_CR1","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.critrevonc.2007.09.001","volume":"66","author":"CC Benz","year":"2008","unstructured":"Benz, C. C. Impact of aging on the biology of breast cancer. Crit. Rev. Oncol. Hematol. 66, 65\u201374 (2008).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"1173_CR2","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/nrc2522","volume":"8","author":"CC Benz","year":"2008","unstructured":"Benz, C. C. & Yau, C. Ageing, oxidative stress and cancer: paradigms in parallax. Nat. Rev. Cancer 8, 875\u2013879 (2008).","journal-title":"Nat. Rev. Cancer"},{"key":"1173_CR3","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/s41416-019-0721-1","volume":"122","author":"E Laconi","year":"2020","unstructured":"Laconi, E., Marongiu, F. & DeGregori, J. Cancer as a disease of old age: changing mutational and microenvironmental landscapes. Br. J. Cancer 122, 943\u2013952 (2020).","journal-title":"Br. J. Cancer"},{"key":"1173_CR4","doi-asserted-by":"publisher","unstructured":"Howlader, N. et al. US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status. J. Natl Cancer Inst. https:\/\/doi.org\/10.1093\/jnci\/dju055 (2014).","DOI":"10.1093\/jnci\/dju055"},{"key":"1173_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22560-y","volume":"12","author":"K Chatsirisupachai","year":"2021","unstructured":"Chatsirisupachai, K., Lesluyes, T., Paraoan, L., Van Loo, P. & de Magalh\u00e3es, J. P. An integrative analysis of the age-associated multi-omic landscape across cancers. Nat. Commun. 12, 2345 (2021).","journal-title":"Nat. Commun."},{"key":"1173_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27889-y","volume":"13","author":"CH Li","year":"2022","unstructured":"Li, C. H., Haider, S. & Boutros, P. C. Age influences on the molecular presentation of tumours. Nat. Commun. 13, 208 (2022).","journal-title":"Nat. Commun."},{"key":"1173_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/bcr1765","volume":"9","author":"C Yau","year":"2007","unstructured":"Yau, C. et al. Aging impacts transcriptomes but not genomes of hormone-dependent breast cancers. Breast Cancer Res. 9, R59 (2007).","journal-title":"Breast Cancer Res."},{"key":"1173_CR8","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/S1357-2725(02)00052-3","volume":"34","author":"S Eppenberger-Castori","year":"2002","unstructured":"Eppenberger-Castori, S. et al. Age-associated biomarker profiles of human breast cancer. Int. J. Biochem. Cell Biol. 34, 1318\u20131330 (2002).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"1173_CR9","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/s43018-020-0060-4","volume":"1","author":"T Osako","year":"2020","unstructured":"Osako, T. et al. Age-correlated protein and transcript expression in breast cancer and normal breast tissues is dominated by host endocrine effects. Nat. Cancer 1, 518\u2013532 (2020).","journal-title":"Nat. Cancer"},{"key":"1173_CR10","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1038\/s41591-019-0675-0","volume":"25","author":"D Furman","year":"2019","unstructured":"Furman, D. et al. Chronic inflammation in the etiology of disease across the life span. Nat. Med. 25, 1822\u20131832 (2019).","journal-title":"Nat. Med."},{"key":"1173_CR11","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/s43587-025-00827-z","volume":"5","author":"LA Trastus","year":"2025","unstructured":"Trastus, L. A. & d\u2019Adda di Fagagna, F. The complex interplay between aging and cancer. Nat. Aging 5, 350\u2013365 (2025).","journal-title":"Nat. Aging"},{"key":"1173_CR12","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41568-023-00635-w","volume":"24","author":"TR Mempel","year":"2024","unstructured":"Mempel, T. R., Lill, J. K. & Altenburger, L. M. How chemokines organize the tumour microenvironment. Nat. Rev. Cancer 24, 28\u201350 (2024).","journal-title":"Nat. Rev. Cancer"},{"key":"1173_CR13","first-page":"78","volume":"71","author":"MS Sedrak","year":"2021","unstructured":"Sedrak, M. S. et al. Older adult participation in cancer clinical trials: a systematic review of barriers and interventions. CA Cancer J. Clin. 71, 78\u201392 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"1173_CR14","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1007\/s00520-018-4558-6","volume":"27","author":"GR Williams","year":"2019","unstructured":"Williams, G. R. et al. Frailty and health-related quality of life in older women with breast cancer. Support. Care Cancer 27, 2693\u20132698 (2019).","journal-title":"Support. Care Cancer"},{"key":"1173_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17644-0","volume":"11","author":"A Buqu\u00e9","year":"2020","unstructured":"Buqu\u00e9, A. et al. Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer. Nat. Commun. 11, 3819 (2020).","journal-title":"Nat. Commun."},{"key":"1173_CR16","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1023\/A:1026443305758","volume":"5","author":"J Russo","year":"2000","unstructured":"Russo, J. & Russo, I. H. Atlas and histologic classification of tumors of the rat mammary gland. J. Mammary Gland Biol. Neoplasia 5, 187\u2013200 (2000).","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"1173_CR17","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1158\/2326-6066.CIR-21-0804","volume":"10","author":"CR Gil Del Alcazar","year":"2022","unstructured":"Gil Del Alcazar, C. R. et al. Insights into immune escape during tumor evolution and response to immunotherapy using a rat model of breast cancer. Cancer Immunol. Res. 10, 680\u2013697 (2022).","journal-title":"Cancer Immunol. Res."},{"key":"1173_CR18","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1093\/jnci\/54.6.1449","volume":"54","author":"B Sass","year":"1975","unstructured":"Sass, B. et al. Incidence of spontaneous neoplasms in F344 rats throughout the natural life-span. J. Natl Cancer Inst. 54, 1449\u20131456 (1975).","journal-title":"J. Natl Cancer Inst."},{"key":"1173_CR19","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/s41571-022-00684-4","volume":"19","author":"N Carleton","year":"2022","unstructured":"Carleton, N. & McAuliffe, P. F. Are the chronological age cutoffs used in clinical oncology guidelines biologically meaningful? Nat. Rev. Clin. Oncol. 19, 745\u2013746 (2022).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1173_CR20","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.6322","volume":"4","author":"N Carleton","year":"2021","unstructured":"Carleton, N. et al. Outcomes after sentinel lymph node biopsy and radiotherapy in older women with early-stage, estrogen receptor-positive breast cancer. JAMA Netw. Open 4, e216322 (2021).","journal-title":"JAMA Netw. Open"},{"key":"1173_CR21","doi-asserted-by":"publisher","first-page":"4293","DOI":"10.1200\/JCO.23.00933","volume":"41","author":"W Dale","year":"2023","unstructured":"Dale, W. et al. Practical assessment and management of vulnerabilities in older patients receiving systemic cancer therapy: ASCO guideline update. J. Clin. Oncol. 41, 4293\u20134312 (2023).","journal-title":"J. Clin. Oncol."},{"key":"1173_CR22","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.6004\/jnccn.2021.0043","volume":"19","author":"E Dotan","year":"2021","unstructured":"Dotan, E. et al. NCCN Guidelines\u00ae insights: older adult oncology, version 1.2021. J. Natl Compr. Canc. Netw. 19, 1006\u20131019 (2021).","journal-title":"J. Natl Compr. Canc. Netw."},{"key":"1173_CR23","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1200\/OP.23.00263","volume":"19","author":"GR Williams","year":"2023","unstructured":"Williams, G. R. et al. Practical assessment and management of vulnerabilities in older patients receiving systemic cancer therapy: ASCO guideline questions and answers. JCO Oncol. Pract. 19, 718\u2013723 (2023).","journal-title":"JCO Oncol. Pract."},{"key":"1173_CR24","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.cmet.2020.05.008","volume":"31","author":"R Qureshi","year":"2020","unstructured":"Qureshi, R. et al. The major pre- and postmenopausal estrogens play opposing roles in obesity-driven mammary inflammation and breast cancer development. Cell Metab. 31, 1154\u20131172.e1159 (2020).","journal-title":"Cell Metab."},{"key":"1173_CR25","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/s43587-021-00082-y","volume":"1","author":"N Sayed","year":"2021","unstructured":"Sayed, N. et al. An inflammatory aging clock (iAge) based on deep learning tracks multimorbidity, immunosenescence, frailty and cardiovascular aging. Nat. Aging 1, 598\u2013615 (2021).","journal-title":"Nat. Aging"},{"key":"1173_CR26","doi-asserted-by":"publisher","unstructured":"Zou, J. et al. Mutual information for detecting multi-class biomarkers when integrating multiple bulk or single-cell transcriptomic studies. Bioinformatics https:\/\/doi.org\/10.1093\/bioinformatics\/btae696 (2024).","DOI":"10.1093\/bioinformatics\/btae696"},{"key":"1173_CR27","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/s41588-021-00911-1","volume":"53","author":"SZ Wu","year":"2021","unstructured":"Wu, S. Z. et al. A single-cell and spatially resolved atlas of human breast cancers. Nat. Genet. 53, 1334\u20131347 (2021).","journal-title":"Nat. Genet."},{"key":"1173_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-015-0618-8","volume":"17","author":"S Liao","year":"2015","unstructured":"Liao, S. et al. The molecular landscape of premenopausal breast cancer. Breast Cancer Res. 17, 104 (2015).","journal-title":"Breast Cancer Res."},{"key":"1173_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-022-00492-0","volume":"8","author":"T Qing","year":"2022","unstructured":"Qing, T. et al. Molecular differences between younger versus older ER-positive and HER2-negative breast cancers. npj Breast Cancer 8, 119 (2022).","journal-title":"npj Breast Cancer"},{"key":"1173_CR30","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1016\/S1470-2045(20)30458-7","volume":"21","author":"I Smith","year":"2020","unstructured":"Smith, I. et al. Long-term outcome and prognostic value of Ki67 after perioperative endocrine therapy in postmenopausal women with hormone-sensitive early breast cancer (POETIC): an open-label, multicentre, parallel-group, randomised, phase 3 trial. Lancet Oncol. 21, 1443\u20131454 (2020).","journal-title":"Lancet Oncol."},{"key":"1173_CR31","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/BF00665786","volume":"34","author":"BL Nguyen","year":"1995","unstructured":"Nguyen, B. L., Chetrite, G. & Pasqualini, J. R. Transformation of estrone and estradiol in hormone-dependent and hormone-independent human breast cancer cells. Effects of the antiestrogen ICI 164,384, danazol, and promegestone (R-5020). Breast Cancer Res. Treat. 34, 139\u2013146 (1995).","journal-title":"Breast Cancer Res. Treat."},{"key":"1173_CR32","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.biochi.2019.12.012","volume":"170","author":"T Ferrante","year":"2020","unstructured":"Ferrante, T. et al. Multiple catalytic activities of human 17\u03b2-hydroxysteroid dehydrogenase type 7 respond differently to inhibitors. Biochimie 170, 106\u2013117 (2020).","journal-title":"Biochimie"},{"key":"1173_CR33","doi-asserted-by":"publisher","first-page":"7488","DOI":"10.1021\/jm900921c","volume":"52","author":"E Bellavance","year":"2009","unstructured":"Bellavance, E., Luu-The, V. & Poirier, D. Potent and selective steroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 7, an enzyme that catalyzes the reduction of the key hormones estrone and dihydrotestosterone. J. Med. Chem. 52, 7488\u20137502 (2009).","journal-title":"J. Med. Chem."},{"key":"1173_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2024.106544","volume":"242","author":"JY Sanc\u00e9au","year":"2024","unstructured":"Sanc\u00e9au, J. Y., Maltais, R., Zhou, M., Lin, S. X. & Poirier, D. Synthesis and characterization of targeted 17\u03b2-hydroxysteroid dehydrogenase type 7 inhibitors. J. Steroid Biochem. Mol. Biol. 242, 106544 (2024).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"1173_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2021.105963","volume":"214","author":"JF Th\u00e9riault","year":"2021","unstructured":"Th\u00e9riault, J. F., Poirier, D. & Lin, S. X. The multi-specific human 17 beta-hydroxysteroid dehydrogenase type 7: non-competitive inhibitors can target different catalyses to facilitate breast cancer treatment. J. Steroid Biochem. Mol. Biol. 214, 105963 (2021).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"1173_CR36","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.it.2022.04.008","volume":"43","author":"RY Ma","year":"2022","unstructured":"Ma, R. Y., Black, A. & Qian, B. Z. Macrophage diversity in cancer revisited in the era of single-cell omics. Trends Immunol. 43, 546\u2013563 (2022).","journal-title":"Trends Immunol."},{"key":"1173_CR37","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/s43018-023-00527-w","volume":"4","author":"S Onkar","year":"2023","unstructured":"Onkar, S. et al. Immune landscape in invasive ductal and lobular breast cancer reveals a divergent macrophage-driven microenvironment. Nat. Cancer 4, 516\u2013534 (2023).","journal-title":"Nat. Cancer"},{"key":"1173_CR38","doi-asserted-by":"publisher","unstructured":"Carleton, N. et al. Use of ctDNA in older women with ER+ breast cancer to facilitate surgical de-escalation: a prospective, hybrid-decentralized trial with correlative studies. Clin. Cancer Res. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-25-4079 (2026).","DOI":"10.1158\/1078-0432.Ccr-25-4079"},{"key":"1173_CR39","doi-asserted-by":"publisher","first-page":"e327","DOI":"10.1016\/S1470-2045(20)30741-5","volume":"22","author":"L Biganzoli","year":"2021","unstructured":"Biganzoli, L. et al. Updated recommendations regarding the management of older patients with breast cancer: a joint paper from the European Society of Breast Cancer Specialists (EUSOMA) and the International Society of Geriatric Oncology (SIOG). Lancet Oncol. 22, e327\u2013e340 (2021).","journal-title":"Lancet Oncol."},{"key":"1173_CR40","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.1016\/S2666-7568(21)00280-4","volume":"3","author":"N Carleton","year":"2022","unstructured":"Carleton, N. et al. Personalising therapy for early-stage oestrogen receptor-positive breast cancer in older women. Lancet Healthy Longev. 3, e54\u2013e66 (2022).","journal-title":"Lancet Healthy Longev."},{"key":"1173_CR41","doi-asserted-by":"publisher","first-page":"e663","DOI":"10.1016\/S2666-7568(21)00179-3","volume":"2","author":"Y Van Herck","year":"2021","unstructured":"Van Herck, Y. et al. Is cancer biology different in older patients? Lancet Healthy Longev. 2, e663\u2013e677 (2021).","journal-title":"Lancet Healthy Longev."},{"key":"1173_CR42","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1002\/cncr.31308","volume":"124","author":"RA Freedman","year":"2018","unstructured":"Freedman, R. A. et al. Breast cancer-specific survival by age: Worse outcomes for the oldest patients. Cancer 124, 2184\u20132191 (2018).","journal-title":"Cancer"},{"key":"1173_CR43","doi-asserted-by":"publisher","unstructured":"Carleton, N. et al. Electronic health record-based nudge intervention and axillary surgery in older women with breast cancer: a nonrandomized controlled trial. JAMA Surg. https:\/\/doi.org\/10.1001\/jamasurg.2024.2407 (2024).","DOI":"10.1001\/jamasurg.2024.2407"},{"key":"1173_CR44","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1001\/jamasurg.2020.0322","volume":"155","author":"T Wang","year":"2020","unstructured":"Wang, T., Baskin, A. S. & Dossett, L. A. Deimplementation of the choosing wisely recommendations for low-value breast cancer surgery: a systematic review. JAMA Surg. 155, 759\u2013770 (2020).","journal-title":"JAMA Surg."},{"key":"1173_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-023-00591-6","volume":"9","author":"M Chadha","year":"2023","unstructured":"Chadha, M. et al. Optimal adjuvant therapy in older (\u226570 years of age) women with low-risk early-stage breast cancer. npj Breast Cancer 9, 99 (2023).","journal-title":"npj Breast Cancer"},{"key":"1173_CR46","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1200\/JCO.23.02289","volume":"42","author":"RW Mutter","year":"2024","unstructured":"Mutter, R. W., Chauhan, C., Goetz, M. P. & Wright, J. L. Revisiting combined modality therapy in older patients with luminal breast cancer through the patient lens. J. Clin. Oncol. 42, 2121\u20132125 (2024).","journal-title":"J. Clin. Oncol."},{"key":"1173_CR47","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1158\/2326-6066.CIR-19-0786","volume":"8","author":"CR Gil Del Alcazar","year":"2020","unstructured":"Gil Del Alcazar, C. R., Ale\u010dkovi\u0107, M. & Polyak, K. Immune escape during breast tumor progression. Cancer Immunol. Res. 8, 422\u2013427 (2020).","journal-title":"Cancer Immunol. Res."},{"key":"1173_CR48","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1126\/science.1203486","volume":"331","author":"RD Schreiber","year":"2011","unstructured":"Schreiber, R. D., Old, L. J. & Smyth, M. J. Cancer immunoediting: integrating immunity\u2019s roles in cancer suppression and promotion. Science 331, 1565\u20131570 (2011).","journal-title":"Science"},{"key":"1173_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108566","volume":"33","author":"CM Li","year":"2020","unstructured":"Li, C. M. et al. Aging-associated alterations in mammary epithelia and stroma revealed by single-cell RNA sequencing. Cell Rep. 33, 108566 (2020).","journal-title":"Cell Rep."},{"key":"1173_CR50","doi-asserted-by":"publisher","unstructured":"Yan, P. et al. Midkine as a driver of age-related changes and increase in mammary tumorigenesis. Cancer Cell https:\/\/doi.org\/10.1016\/j.ccell.2024.09.002 (2024).","DOI":"10.1016\/j.ccell.2024.09.002"},{"key":"1173_CR51","doi-asserted-by":"publisher","first-page":"4948","DOI":"10.1158\/1078-0432.CCR-11-0043","volume":"17","author":"PE L\u00f8nning","year":"2011","unstructured":"L\u00f8nning, P. E. et al. Exploring breast cancer estrogen disposition: the basis for endocrine manipulation. Clin. Cancer Res. 17, 4948\u20134958 (2011).","journal-title":"Clin. Cancer Res."},{"key":"1173_CR52","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1158\/1078-0432.CCR-09-2481","volume":"16","author":"BP Haynes","year":"2010","unstructured":"Haynes, B. P. et al. Intratumoral estrogen disposition in breast cancer. Clin. Cancer Res. 16, 1790\u20131801 (2010).","journal-title":"Clin. Cancer Res."},{"key":"1173_CR53","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.steroids.2011.02.040","volume":"76","author":"PE L\u00f8nning","year":"2011","unstructured":"L\u00f8nning, P. E. et al. Recent data on intratumor estrogens in breast cancer. Steroids 76, 786\u2013791 (2011).","journal-title":"Steroids"},{"key":"1173_CR54","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jsbmb.2009.06.005","volume":"117","author":"PE L\u00f8nning","year":"2009","unstructured":"L\u00f8nning, P. E. et al. Tissue estradiol is selectively elevated in receptor positive breast cancers while tumour estrone is reduced independent of receptor status. J. Steroid Biochem. Mol. Biol. 117, 31\u201341 (2009).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"1173_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111672","volume":"41","author":"R Qureshi","year":"2022","unstructured":"Qureshi, R. et al. Estrone, the major postmenopausal estrogen, binds ERa to induce SNAI2, epithelial-to-mesenchymal transition, and ER+ breast cancer metastasis. Cell Rep. 41, 111672 (2022).","journal-title":"Cell Rep."},{"key":"1173_CR56","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1200\/JCO.2009.23.9616","volume":"28","author":"AK Dunbier","year":"2010","unstructured":"Dunbier, A. K. et al. Relationship between plasma estradiol levels and estrogen-responsive gene expression in estrogen receptor-positive breast cancer in postmenopausal women. J. Clin. Oncol. 28, 1161\u20131167 (2010).","journal-title":"J. Clin. Oncol."},{"key":"1173_CR57","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1038\/s43587-025-00984-1","volume":"5","author":"A Parsons","year":"2025","unstructured":"Parsons, A. et al. Cell populations in human breast cancers are molecularly and biologically distinct with age. Nat. Aging 5, 2546\u20132563 (2025).","journal-title":"Nat. Aging"},{"key":"1173_CR58","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1184","volume":"9","author":"L Berben","year":"2020","unstructured":"Berben, L. et al. Age-related remodelling of the blood immunological portrait and the local tumor immune response in patients with luminal breast cancer. Clin. Transl. Immunology 9, e1184 (2020).","journal-title":"Clin. Transl. Immunology"},{"key":"1173_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.674192","volume":"12","author":"J Goldberg","year":"2021","unstructured":"Goldberg, J. et al. The immunology of hormone receptor positive breast cancer. Front. Immunol. 12, 674192 (2021).","journal-title":"Front. Immunol."},{"key":"1173_CR60","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s10911-021-09495-2","volume":"26","author":"A Zirbes","year":"2021","unstructured":"Zirbes, A. et al. Changes in immune cell types with age in breast are consistent with a decline in immune surveillance and increased immunosuppression. J. Mammary Gland Biol. Neoplasia 26, 247\u2013261 (2021).","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"1173_CR61","doi-asserted-by":"publisher","first-page":"3794","DOI":"10.1158\/1078-0432.CCR-15-0204","volume":"21","author":"S Svensson","year":"2015","unstructured":"Svensson, S. et al. CCL2 and CCL5 are novel therapeutic targets for estrogen-dependent breast cancer. Clin. Cancer Res. 21, 3794\u20133805 (2015).","journal-title":"Clin. Cancer Res."},{"key":"1173_CR62","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1093\/gerona\/glu057","volume":"69","author":"C Franceschi","year":"2014","unstructured":"Franceschi, C. & Campisi, J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J. Gerontol. A Biol. Sci. Med. Sci. 69, S4\u2013S9 (2014).","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"1173_CR63","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nri.2017.49","volume":"17","author":"N Nagarsheth","year":"2017","unstructured":"Nagarsheth, N., Wicha, M. S. & Zou, W. Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy. Nat. Rev. Immunol. 17, 559\u2013572 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"1173_CR64","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.immuni.2021.01.012","volume":"54","author":"AJ Ozga","year":"2021","unstructured":"Ozga, A. J., Chow, M. T. & Luster, A. D. Chemokines and the immune response to cancer. Immunity 54, 859\u2013874 (2021).","journal-title":"Immunity"},{"key":"1173_CR65","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/s43587-024-00751-8","volume":"5","author":"BL Angarola","year":"2025","unstructured":"Angarola, B. L. et al. Comprehensive single-cell aging atlas of healthy mammary tissues reveals shared epigenomic and transcriptomic signatures of aging and cancer. Nat. Aging 5, 122\u2013143 (2025).","journal-title":"Nat. Aging"},{"key":"1173_CR66","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1210\/endrev\/bnac017","volume":"44","author":"B Chakraborty","year":"2023","unstructured":"Chakraborty, B. et al. Estrogen receptor signaling in the immune system. Endocr. Rev. 44, 117\u2013141 (2023).","journal-title":"Endocr. Rev."},{"key":"1173_CR67","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1158\/0008-5472.CAN-22-1829","volume":"83","author":"E Hargrove-Wiley","year":"2023","unstructured":"Hargrove-Wiley, E. & Fingleton, B. Sex hormones in breast cancer immunity. Cancer Res. 83, 12\u201319 (2023).","journal-title":"Cancer Res."},{"key":"1173_CR68","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1200\/JCO.2024.42.16_suppl.572","volume":"42","author":"SL Sammons","year":"2024","unstructured":"Sammons, S. L. et al. The immunomodulatory impacts of endocrine therapy on host immunity in early-stage hormone receptor positive, HER2 negative breast cancer. J. Clin. Oncol. 42, 572 (2024).","journal-title":"J. Clin. Oncol."},{"key":"1173_CR69","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.it.2019.02.003","volume":"40","author":"P Pathria","year":"2019","unstructured":"Pathria, P., Louis, T. L. & Varner, J. A. Targeting tumor-associated macrophages in cancer. Trends Immunol. 40, 310\u2013327 (2019).","journal-title":"Trends Immunol."},{"key":"1173_CR70","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1177\/0192623315570339","volume":"43","author":"MC Cora","year":"2015","unstructured":"Cora, M. C., Kooistra, L. & Travlos, G. Vaginal cytology of the laboratory rat and mouse: review and criteria for the staging of the estrous cycle using stained vaginal smears. Toxicol. Pathol. 43, 776\u2013793 (2015).","journal-title":"Toxicol. Pathol."},{"key":"1173_CR71","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1093\/nar\/gkt214","volume":"41","author":"Y Liao","year":"2013","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote. Nucleic Acids Res. 41, e108 (2013).","journal-title":"Nucleic Acids Res."},{"key":"1173_CR72","doi-asserted-by":"publisher","first-page":"4288","DOI":"10.1093\/nar\/gks042","volume":"40","author":"DJ McCarthy","year":"2012","unstructured":"McCarthy, D. J., Chen, Y. & Smyth, G. K. Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation. Nucleic Acids Res. 40, 4288\u20134297 (2012).","journal-title":"Nucleic Acids Res."},{"key":"1173_CR73","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"1173_CR74","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s12064-012-0162-3","volume":"131","author":"GP Wagner","year":"2012","unstructured":"Wagner, G. P., Kin, K. & Lynch, V. J. Measurement of mRNA abundance using RNA-seq data: RPKM measure is inconsistent among samples. Theory Biosci. 131, 281\u2013285 (2012).","journal-title":"Theory Biosci."},{"key":"1173_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02391-6","volume":"9","author":"M Schubert","year":"2018","unstructured":"Schubert, M. et al. Perturbation-response genes reveal signaling footprints in cancer gene expression. Nat. Commun. 9, 20 (2018).","journal-title":"Nat. Commun."},{"key":"1173_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann, S., Castelo, R. & Guinney, J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics 14, 1\u201315 (2013).","journal-title":"BMC Bioinformatics"},{"key":"1173_CR77","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s10549-011-1746-1","volume":"133","author":"AC Degnim","year":"2012","unstructured":"Degnim, A. C. et al. Histologic findings in normal breast tissues: comparison to reduction mammaplasty and benign breast disease tissues. Breast Cancer Res. Treat. 133, 169\u2013177 (2012).","journal-title":"Breast Cancer Res. Treat."},{"key":"1173_CR78","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1158\/1940-6207.CAPR-11-0234","volume":"5","author":"ME Sherman","year":"2012","unstructured":"Sherman, M. E. et al. The Susan G. Komen for the Cure Tissue Bank at the IU Simon Cancer Center: a unique resource for defining the \u201cmolecular histology\u201d of the breast. Cancer Prev. Res. 5, 528\u2013535 (2012).","journal-title":"Cancer Prev. Res."},{"key":"1173_CR79","doi-asserted-by":"publisher","unstructured":"Chang, A. C. et al. CITEgeist: cellular indexing of transcriptomes and epitopes for guided exploration of intrinsic spatial trends. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2025.02.15.638331 (2025).","DOI":"10.1101\/2025.02.15.638331"},{"key":"1173_CR80","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.contraception.2018.12.010","volume":"99","author":"J Zhang","year":"2019","unstructured":"Zhang, J. et al. A sensitive and robust UPLC-MS\/MS method for quantitation of estrogens and progestogens in human serum. Contraception 99, 244\u2013250 (2019).","journal-title":"Contraception"},{"key":"1173_CR81","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587. e3529 (2021).","journal-title":"Cell"},{"key":"1173_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1874-1","volume":"20","author":"C Hafemeister","year":"2019","unstructured":"Hafemeister, C. & Satija, R. Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression. Genome Biol. 20, 296 (2019).","journal-title":"Genome Biol."},{"key":"1173_CR83","doi-asserted-by":"crossref","unstructured":"McInnes, L., Healy, J., and Melville, J. UMAP: Uniform Manifold Approximation and Projection for dimension reduction. Preprint at https:\/\/arxiv.org\/abs\/1802.03426 (2018).","DOI":"10.21105\/joss.00861"},{"key":"1173_CR84","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/s41586-022-04918-4","volume":"607","author":"L Garcia-Alonso","year":"2022","unstructured":"Garcia-Alonso, L. et al. Single-cell roadmap of human gonadal development. Nature 607, 540\u2013547 (2022).","journal-title":"Nature"},{"key":"1173_CR85","doi-asserted-by":"crossref","unstructured":"Comprehensive molecular portraits of human breast tumours. Nature 490, 61\u201370 (2012).","DOI":"10.1038\/nature11412"},{"key":"1173_CR86","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature10983","volume":"486","author":"C Curtis","year":"2012","unstructured":"Curtis, C. et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 486, 346\u2013352 (2012).","journal-title":"Nature"},{"key":"1173_CR87","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202012118","volume":"12","author":"C Brueffer","year":"2020","unstructured":"Brueffer, C. et al. The mutational landscape of the SCAN-B real-world primary breast cancer transcriptome. EMBO Mol. Med. 12, e12118 (2020).","journal-title":"EMBO Mol. Med."},{"key":"1173_CR88","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-015-0131-9","volume":"7","author":"LH Saal","year":"2015","unstructured":"Saal, L. H. et al. The Sweden Cancerome Analysis Network - Breast (SCAN-B) Initiative: a large-scale multicenter infrastructure towards implementation of breast cancer genomic analyses in the clinical routine. Genome Med. 7, 20 (2015).","journal-title":"Genome Med."},{"key":"1173_CR89","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.cell.2017.11.010","volume":"172","author":"N Sachs","year":"2018","unstructured":"Sachs, N. et al. A living biobank of breast cancer organoids captures disease heterogeneity. Cell 172, 373\u2013386.e310 (2018).","journal-title":"Cell"},{"key":"1173_CR90","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1016\/j.bmc.2007.11.007","volume":"16","author":"Y Laplante","year":"2008","unstructured":"Laplante, Y., Cadot, C., Fournier, M. A. & Poirier, D. Estradiol and estrone C-16 derivatives as inhibitors of type 1 17beta-hydroxysteroid dehydrogenase: blocking of ER+ breast cancer cell proliferation induced by estrone. Bioorg. Med. Chem. 16, 1849\u20131860 (2008).","journal-title":"Bioorg. Med. Chem."},{"key":"1173_CR91","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-021-04344-9","volume":"22","author":"DR Stirling","year":"2021","unstructured":"Stirling, D. R. et al. CellProfiler 4: improvements in speed, utility and usability. BMC Bioinformatics 22, 433 (2021).","journal-title":"BMC Bioinformatics"},{"key":"1173_CR92","doi-asserted-by":"publisher","unstructured":"Carleton, N. Systemic and local chronic inflammation and hormone disposition promote a tumor-permissive environment for breast cancer in older women. figshare https:\/\/doi.org\/10.6084\/m9.figshare.32620215.v1 (2026).","DOI":"10.6084\/m9.figshare.32620215.v1"}],"container-title":["Nature Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43587-026-01173-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43587-026-01173-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43587-026-01173-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T12:02:14Z","timestamp":1786622534000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43587-026-01173-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":92,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["1173"],"URL":"https:\/\/doi.org\/10.1038\/s43587-026-01173-4","relation":{},"ISSN":["2662-8465"],"issn-type":[{"value":"2662-8465","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]},"assertion":[{"value":"20 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}